Sign Up For Updates
Sign up for updates
Join our mailing list to receive updates from the Drug Pricing Lab.
Thank you for signing up to receive news and information from the Drug Pricing Lab.
Return to Previous Page
The U.S. Government Should Buy Gilead For $156 Billion To Save Money On Hepatitis C
Peter B. Bach and Mark R. Trusheim propose that the U.S. Government buy Gilead from its shareholders.
Evidence Driven Drug Pricing Project
January 17, 2017
No Results Found